Inventor · disambiguated record
Ru Chih C. Huang
Also filed as: HUANG RU · HUANG RU C · HUANG RU C C · HUANG RU CHIH
26 granted patents·8 pending applications·270 citations·filing 1993–2025
96Inventor score
Files withUNIV JOHNS HOPKINS22HUANG RU CHIH C7BEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD1BENGBU MEDICAL UNIV1ERIMOS PHARMACEUTICALS LLC1
Top patents by PatentIndex Score
34 records- 0190US7741357B1Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agentsUNIV JOHNS HOPKINS·Filed 2007·Granted Jun 22, 2010·17 cites·10 claims
- 0289US6608108B2Method for treatment of tumors using nordihydroguaiaretic acid derivativesUNIV JOHNS HOPKINS·Filed 2001·Granted Aug 19, 2003·24 cites·52 claims
- 0388US6777444B2Method for regulation of gene expression in eukaryotic cells using nordihydroguaiaretic acid derivativesUNIV JOHNS HOPKINS·Filed 2002·Granted Aug 17, 2004·20 cites·43 claims
- 0487US6417234B1Nordihydroguaiaretic derivatives for use in treatment of tumorsUNIV JOHNS HOPKINS·Filed 2000·Granted Jul 9, 2002·29 cites·9 claims
- 0584US6958411B2Nordihydroguaiartic derivatives for use in treatment of tumorsUNIV JOHNS HOPKINS·Filed 2002·Granted Oct 25, 2005·16 cites·16 claims
- 0683US9259433B2Synergistic antiviral compositions comprising a viral attachment inhibitor, an integration inhibitor, and a proviral transcription inhibitor, and their useUNIV JOHNS HOPKINS·Filed 2015·Granted Feb 16, 2016·3 cites·5 claims
- 0780US7728036B2Methods for delivery of catecholic butanes for treatment of tumorsERIMOS PHARMACEUTICALS LLC·Filed 2005·Granted Jun 1, 2010·10 cites·95 claims
- 0880US6214874B1Treatment of HPV induced cancer using in situ application of two nordihydroguiaretic acid derivatives, tetramethyl NDGA M4N and tetraglycinal NDGA G4NUNIV JOHNS HOPKINS·Filed 1999·Granted Apr 10, 2001·40 cites·15 claims
- 0979US9456995B2Methods for inhibition of BNIP3 and prevention and treatment of ischemia reperfusion injury by tetra-O-methyl nordihydroguaiaretic acidUNIV JOHNS HOPKINS·Filed 2013·Granted Oct 4, 2016·2 cites·4 claims
- 1079US9005889B2Synergistic antiviral compositions comprising a viral attachment inhibitor, integration inhibitor, and proviral transcription inhibitorHUANG RU CHIH C·Filed 2008·Granted Apr 14, 2015·2 cites·4 claims
- 1179US8318815B2Method for treatment of tumors using nordihydroguaiaretic acid derivativesHUANG RU CHIH C·Filed 2003·Granted Nov 27, 2012·11 cites·5 claims
- 1277US9101567B2Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporineHUANG RU CHIH C·Filed 2011·Granted Aug 11, 2015·2 cites·11 claims
- 1375US8420692B1Heterocyclic and carbonate derivatives of NDGA and their use as new anti-HIV and anti-cancer agentsHUANG RU CHIH C·Filed 2010·Granted Apr 16, 2013·2 cites·29 claims
- 1473US9149526B2Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulatorsHUANG RU CHIH·Filed 2009·Granted Oct 6, 2015·1 cites·6 claims
- 1573US6291524B1Method for the suppression of viral growthUNIV JOHNS HOPKINS·Filed 1997·Granted Sep 18, 2001·29 cites·3 claims
- 1671USRE46907ESuppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with metabolic modulatorsUNIV JOHNS HOPKINS·Filed 2009·Granted Jun 26, 2018·1 cites·14 claims
- 1771US6365787B1Compounds for the suppression of HIV TAT transactivationUNIV JOHNS HOPKINS·Filed 1994·Granted Apr 2, 2002·18 cites·8 claims
- 1869US5663209ACompounds for the suppression of HIV Tat transactivationUNIV JOHNS HOPKINS·Filed 1996·Granted Sep 2, 1997·20 cites·11 claims
- 1967US8440648B2Methods and compositions for treatment of intraepithelial neoplasiaFRAZER NEIL·Filed 2005·Granted May 14, 2013·1 cites·13 claims
- 2063USRE40246EMethod for the suppression of viral growthUNIV JOHNS HOPKINS·Filed 2003·Granted Apr 15, 2008·0 cites·37 claims
- 2162US9877978B2Compositions comprising NDGA derivatives and sorafenib and their use in treatment of cancerUNIV JOHNS HOPKINS·Filed 2013·Granted Jan 30, 2018·1 cites·11 claims
- 2262US9084779B2Conjugates of nitroimidazoles and their use as chemotherapeutic agentsHUANG RU CHIH C·Filed 2012·Granted Jul 21, 2015·1 cites·27 claims
- 2362US7071227B2Antiviral compositions and methods of useUNIV JOHNS HOPKINS·Filed 2001·Granted Jul 4, 2006·5 cites·11 claims
- 2459US2019381026A1In vivo amelioration of endogenous anti-tumor autoantibodies targeting surface tumor antigens via low-dose p4nUNIV JOHNS HOPKINS·Filed 2019·Application pending·0 cites
- 2553US2005267208A1Nordihydroguaiartic derivatives for use in treatment of tumorsUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 2651US2025360096A1Use of compound k67 in preparation of anti-tuberculosis drugBENGBU MEDICAL UNIV·Filed 2025·Application pending·0 cites
- 2750US12171729B2Formulations of terameprocol and temozolomide and their use in stimulation of humoral immunity in tumorsUNIV JOHNS HOPKINS·Filed 2020·Granted Dec 24, 2024·0 cites·21 claims
- 2850US5445954ASystem for automatic gene amplification and expressionUNIV JOHNS HOPKINS·Filed 1993·Granted Aug 29, 1995·15 cites·4 claims
- 2946US9284565B2Bacterial expression plasmidHUANG RU CHIH C·Filed 2012·Granted Mar 15, 2016·0 cites·17 claims
- 3046US2024383970A1Antibody specifically binding to strep-tag ii tag and use thereofBEIJING IMMUNOCHINA PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 3142US2019111040A1In vivo amelioration of endogenous anti-tumor autoantibodies targeting surface tumor antigens via low-dose p4nUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 3240US2008207532A1Use of Nordihydroguaiaretic Acid Derivatives in the Treatment of Drug Resistant Cancer, Viral and Microbial InfectionUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 3338US2006141047A1Methods and compositions for delivery of catecholic butanes for treatment of obesityUNIV JOHNS HOPKINS·Filed 2005·Application pending·0 cites
- 3438US2011135711A1Methods and Compositions for Delivery of Catecholic Butanes for Treatment of TumorsHUANG RU CHIH C·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →